Testicular germ cell tumours (TGCTs) are the most common cause of cancer in men between the ages of 15 and 40 years, and, overall, the majority of patients should expect to be cured. The European Germ Cell Cancer Consensus Group has provided clear guidelines for the primary treatment of both seminoma and nonseminomatous germ cell tumours. There is, however, no international consensus on how best to follow patients after their initial management. This must promptly and reliably identify relapses without causing further harm. The standardising of follow-up would result in optimising risk-benefit ratios for individual patients, while ensuring economic use of resources. We have identified the seven common scenarios in managing seminomas and nonseminomas of the various stages and discuss the pertinent issues around relapse and follow-up. We review the available literature and present our comprehensive TGCT follow-up guidelines. Our protocols provide a pragmatic, easily accessible user-friendly basis for other centres to use or to adapt to suit their needs. Furthermore, this should enable future trials to address specific issues around follow-up giving meaningful and useful results.
Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse
N. V. As,D. Gilbert,J. Money-Kyrle,D. Bloomfield,S. Beesley,D. Dearnaley,A. Horwich,R. Huddart
Published 2008 in British Journal of Cancer
ABSTRACT
PUBLICATION RECORD
- Publication year
2008
- Venue
British Journal of Cancer
- Publication date
2008-06-10
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-83 of 83 references · Page 1 of 1
CITED BY
Showing 1-98 of 98 citing papers · Page 1 of 1